About Pregnolia
Pregnolia is a company based in Zurich (Switzerland) founded in 2015. Pregnolia has raised $10.23 million across 10 funding rounds from investors including Zurcher Kantonalbank, European Union and CADFEM. Pregnolia offers products and services including Pregnolia System. Pregnolia operates in a competitive market with competitors including Sera Prognostics, Mirvie, Yourgene Health, NX Prenatal and Rea Diagnostics, among others.
- Headquarter Zurich, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pregnolia Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.23 M (USD)
in 10 rounds
-
Latest Funding Round
$2.49 M (USD), Series A
Nov 21, 2023
-
Investors
Zurcher Kantonalbank
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pregnolia
Pregnolia offers a comprehensive portfolio of products and services, including Pregnolia System.
Measures cervical stiffness to assess premature birth risk.
People of Pregnolia
Unlock access to complete
Unlock access to complete
Funding Insights of Pregnolia
Pregnolia has successfully raised a total of $10.23M across 10 strategic funding rounds. The most recent funding activity was a Series A round of $2.49 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pregnolia
Pregnolia has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Zurcher Kantonalbank, European Union and CADFEM.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Venture capital firm focused on science and tech-driven startups
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Pregnolia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pregnolia
Investment portfolio details for Pregnolia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pregnolia
Detailed financials for Pregnolia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pregnolia Comparisons
Peer comparison for Pregnolia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pregnolia
Pregnolia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sera Prognostics, Mirvie, Yourgene Health, NX Prenatal and Rea Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sera Prognostics is focused on women's health diagnostics.
|
|
| Locked | Locked | Locked |
Non-invasive blood tests for prenatal fetal health predictions are offered.
|
|
| Locked | Locked | Locked |
Non-invasive prenatal genetic tests and genomic services are provided.
|
|
| Locked | Locked | Locked |
Early warning blood tests for pregnancy complications are provided.
|
|
| Locked | Locked | Locked |
Wearable diagnostic device is provided to monitor preterm birth risks.
|
Detailed competitors of Pregnolia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pregnolia
Complete news archive for Pregnolia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pregnolia
Pregnolia was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Pregnolia is headquartered in Zurich, Switzerland.
Pregnolia is a funded company, having raised a total of $10.23M across 10 funding rounds to date.
Pregnolia was founded in 2015 in Zurich, Switzerland, within the medical device sector. A flagship product featuring an intra-vaginal probe is offered to assess cervical stiffness, a parameter linked to preterm birth diagnosis. Clinical validation of the device is ongoing. Operations focus on healthcare technology for maternal health, with emphasis on predictive diagnostics in European markets.
Pregnolia's top competitors include Mirvie, NX Prenatal and Yourgene Health.
Pregnolia offers Pregnolia System.
Pregnolia has 5 investors. Key investors include Zurcher Kantonalbank, European Union, CADFEM, EIC Fund, and Verve Ventures.